Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
Exon-skipping therapies such as systemic i.v. administration of morpholino are being explored as a means of treating Duchenne muscular dystrophy. Here the authors show that adding a glucose-fructose mix can enhance uptake of phosphorodiamidate morpholino oligomer and its therapeutic effect in mdxmic...
Enregistré dans:
| Auteurs principaux: | Gang Han, Ben Gu, Limin Cao, Xianjun Gao, Qingsong Wang, Yiqi Seow, Ning Zhang, Matthew J. A. Wood, HaiFang Yin |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2016
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/6693a2a52ec647acbff8c2322364c6d0 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice
par: Wang M, et autres
Publié: (2015) -
Increased neointimal thickening in dystrophin-deficient mdx mice.
par: Uwe Rauch, et autres
Publié: (2012) -
Intramuscular Evaluation of Chimeric Locked Nucleic Acid/2′<i>O</i>Methyl-Modified Antisense Oligonucleotides for Targeted Exon 23 Skipping in Mdx Mice
par: Michaella Georgiadou, et autres
Publié: (2021) -
Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
par: Franciscus C. Vermeer, et autres
Publié: (2021) -
Machine learning based CRISPR gRNA design for therapeutic exon skipping.
par: Wilson Louie, et autres
Publié: (2021)